ICU Medical (ICUI) Stock Forecast, Price Target & Predictions
ICUI Stock Forecast
ICU Medical stock forecast is as follows: an average price target of $190.50 (represents a 12.14% upside from ICUI’s last price of $169.87) and a rating consensus of 'Buy', based on 4 wall street analysts offering a 1-year stock forecast.
ICUI Price Target
The average price target for ICU Medical (ICUI) is $190.50 based on 1-year price targets from 4 Wall Street analysts in the past 3 months, with a price target range of $198.00 to $183.00. This represents a potential 12.14% upside from ICUI's last price of $169.87.
ICUI Analyst Ratings
According to 4 Wall Street analysts, ICU Medical's rating consensus is 'Buy'. The analyst rating breakdown for ICUI stock is 0 'Strong Buy' (0.00%), 2 'Buy' (50.00%), 2 'Hold' (50.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
ICU Medical Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Oct 15, 2024 | Brett Fishbin | KeyBanc | $198.00 | $180.30 | 9.82% | 16.56% |
| Oct 14, 2024 | Michael Toomey | Jefferies | $183.00 | $178.72 | 2.39% | 7.73% |
| Jun 17, 2024 | Jayson Bedford | Raymond James | $135.00 | $117.44 | 14.96% | -20.53% |
| Aug 09, 2022 | Raymond James | $190.00 | $188.10 | 1.01% | 11.85% | |
| Aug 08, 2022 | Raymond James | $208.00 | $179.63 | 15.79% | 22.45% | |
| May 10, 2022 | Raymond James | $235.00 | $201.17 | 16.82% | 38.34% |
The latest ICU Medical stock forecast, released on Oct 15, 2024 by Brett Fishbin from KeyBanc, set a price target of $198.00, which represents a 9.82% increase from the stock price at the time of the forecast ($180.30), and a 16.56% increase from ICUI last price ($169.87).
ICU Medical Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 3 |
| Avg Price Target | - | - | $172.00 |
| Last Closing Price | $169.87 | $169.87 | $169.87 |
| Upside/Downside | -100.00% | -100.00% | 1.25% |
In the current month, the average price target of ICU Medical stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to ICU Medical's last price of $169.87. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Oct 15, 2024 | KeyBanc | Overweight | Overweight | Hold |
| Oct 14, 2024 | Jefferies | Hold | Initialise | |
| Sep 12, 2024 | Raymond James | Outperform | Outperform | Hold |
| Aug 08, 2024 | Raymond James | Outperform | Outperform | Hold |
| Jun 21, 2024 | Needham | Hold | Initialise | |
| Aug 08, 2022 | Raymond James | Outperform | Outperform | Hold |
| May 10, 2022 | Raymond James | Outperform | Outperform | Hold |
| Feb 28, 2022 | Raymond James | Outperform | Outperform | Hold |
ICU Medical's last stock rating was published by KeyBanc on Oct 15, 2024. The company gave ICUI a "Overweight" rating, the same as its previous rate.
ICU Medical Financial Forecast
ICU Medical Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $587.86M | - | $549.31M | $568.65M | $578.01M | $597.86M | $561.00M | $543.12M | $340.52M | $336.06M | $321.68M | $318.05M | $320.45M | $318.57M | $303.38M | $328.61M | $315.52M | $307.47M |
| Avg Forecast | $639.00M | $624.00M | $624.00M | $590.00M | $613.00M | $600.00M | $600.00M | $569.00M | $593.86M | $574.60M | $556.64M | $552.25M | $562.98M | $565.75M | $565.20M | $561.13M | $578.77M | $565.00M | $559.93M | $553.17M | $319.90M | $314.30M | $305.87M | $300.90M | $295.33M | $284.70M | $276.70M | $296.30M | $295.70M | $291.17M |
| High Forecast | $639.00M | $624.00M | $624.00M | $590.00M | $613.00M | $600.00M | $600.00M | $569.00M | $607.76M | $576.93M | $556.64M | $552.25M | $566.10M | $565.75M | $565.20M | $561.13M | $583.06M | $565.00M | $559.93M | $553.17M | $319.90M | $314.30M | $305.87M | $300.90M | $295.33M | $284.70M | $276.70M | $296.30M | $295.70M | $291.17M |
| Low Forecast | $639.00M | $624.00M | $624.00M | $590.00M | $613.00M | $600.00M | $600.00M | $569.00M | $579.96M | $572.28M | $556.64M | $552.25M | $558.42M | $565.75M | $565.20M | $561.13M | $573.80M | $565.00M | $559.93M | $553.17M | $319.90M | $314.30M | $305.87M | $300.90M | $295.33M | $284.70M | $276.70M | $296.30M | $295.70M | $291.17M |
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 4 | 6 | 4 | 4 | 7 | 4 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.04% | - | 0.97% | 1.01% | 1.00% | 1.06% | 1.00% | 0.98% | 1.06% | 1.07% | 1.05% | 1.06% | 1.09% | 1.12% | 1.10% | 1.11% | 1.07% | 1.06% |
ICU Medical's average Quarter revenue forecast for Mar 24 based on 1 analysts is $552.25M, with a low forecast of $552.25M, and a high forecast of $552.25M. ICUI's average Quarter revenue forecast represents a -6.06% decrease compared to the company's last Quarter revenue of $587.86M (Dec 23).
ICU Medical EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 4 | 6 | 4 | 4 | 7 | 4 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $-12.18M | - | $2.76M | $75.18M | $7.41M | $68.79M | $-14.25M | $45.89M | $46.84M | $55.56M | $59.57M | $51.78M | $54.23M | $50.58M | $45.45M | $43.84M | $43.09M | $54.08M |
| Avg Forecast | $86.51M | $84.47M | $84.47M | $79.87M | $82.99M | $81.23M | $81.23M | $77.03M | $80.39M | $77.79M | $75.36M | $12.05M | $76.21M | $76.59M | $76.51M | $10.95M | $45.87M | $63.34M | $62.77M | $11.71M | $35.86M | $35.24M | $34.29M | $47.64M | $33.11M | $31.92M | $31.02M | $39.00M | $33.15M | $32.64M |
| High Forecast | $86.51M | $84.47M | $84.47M | $79.87M | $82.99M | $81.23M | $81.23M | $77.03M | $82.28M | $78.10M | $75.36M | $14.45M | $76.64M | $76.59M | $76.51M | $13.14M | $55.04M | $63.34M | $62.77M | $14.05M | $35.86M | $35.24M | $34.29M | $57.17M | $33.11M | $31.92M | $31.02M | $46.80M | $33.15M | $32.64M |
| Low Forecast | $86.51M | $84.47M | $84.47M | $79.87M | $82.99M | $81.23M | $81.23M | $77.03M | $78.51M | $77.47M | $75.36M | $9.64M | $75.60M | $76.59M | $76.51M | $8.76M | $36.69M | $63.34M | $62.77M | $9.37M | $35.86M | $35.24M | $34.29M | $38.11M | $33.11M | $31.92M | $31.02M | $31.20M | $33.15M | $32.64M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | -0.16% | - | 0.04% | 6.87% | 0.16% | 1.09% | -0.23% | 3.92% | 1.31% | 1.58% | 1.74% | 1.09% | 1.64% | 1.58% | 1.47% | 1.12% | 1.30% | 1.66% |
1 analysts predict ICUI's average Quarter EBITDA for Sep 23 to be $76.59M, with a high of $76.59M and a low of $76.59M. This is 2674.97% upper than ICU Medical's previous annual EBITDA (Jun 23) of $2.76M.
ICU Medical Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 4 | 6 | 4 | 4 | 7 | 4 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $-17.15M | - | $-9.93M | $-9.81M | $-15.54M | $-13.21M | $-7.47M | $-38.07M | $19.93M | $31.08M | $28.40M | $23.73M | $26.14M | $24.99M | $18.91M | $16.83M | $20.64M | $26.56M |
| Avg Forecast | $57.61M | $53.49M | $51.40M | $41.27M | $49.00M | $45.09M | $42.64M | $33.36M | $36.22M | $30.54M | $24.39M | $-38.27M | $29.14M | $33.85M | $39.10M | $-34.79M | $19.51M | $35.70M | $40.49M | $-37.21M | $40.09M | $43.83M | $40.00M | $21.83M | $36.83M | $31.87M | $30.25M | $14.98M | $39.76M | $39.44M |
| High Forecast | $57.61M | $53.49M | $51.40M | $41.27M | $49.00M | $45.09M | $42.64M | $33.36M | $37.69M | $30.61M | $24.39M | $-30.62M | $29.88M | $33.88M | $39.10M | $-27.83M | $23.41M | $35.70M | $40.49M | $-29.77M | $40.09M | $43.83M | $40.00M | $26.20M | $36.83M | $31.87M | $30.25M | $17.97M | $39.76M | $39.44M |
| Low Forecast | $57.61M | $53.49M | $51.40M | $41.27M | $49.00M | $45.09M | $42.64M | $33.36M | $34.75M | $30.47M | $24.39M | $-45.93M | $27.91M | $33.81M | $39.10M | $-41.75M | $15.61M | $35.70M | $40.49M | $-44.66M | $40.09M | $43.83M | $40.00M | $17.47M | $36.83M | $31.87M | $30.25M | $11.98M | $39.76M | $39.44M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | -0.59% | - | -0.25% | 0.28% | -0.80% | -0.37% | -0.18% | 1.02% | 0.50% | 0.71% | 0.71% | 1.09% | 0.71% | 0.78% | 0.63% | 1.12% | 0.52% | 0.67% |
ICU Medical's average Quarter net income forecast for Mar 22 is $-37.21M, with a range of $-44.66M to $-29.77M. ICUI's average Quarter net income forecast represents a -286.76% decrease compared to the company's last Quarter net income of $19.93M (Dec 21).
ICU Medical SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 4 | 6 | 4 | 4 | 7 | 4 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $154.62M | - | $150.90M | $152.57M | $142.93M | $153.45M | $158.75M | $153.21M | $81.46M | $74.81M | $73.92M | $72.39M | $73.55M | $70.85M | $67.24M | $72.31M | $70.65M | $65.88M |
| Avg Forecast | $154.31M | $150.68M | $150.68M | $142.47M | $148.03M | $144.89M | $144.89M | $137.40M | $143.41M | $138.76M | $134.42M | $154.04M | $135.95M | $136.62M | $136.48M | $140.03M | $79.77M | $135.34M | $134.13M | $149.77M | $76.63M | $75.29M | $73.27M | $66.60M | $70.75M | $68.20M | $66.28M | $64.32M | $70.83M | $69.75M |
| High Forecast | $154.31M | $150.68M | $150.68M | $142.47M | $148.03M | $144.89M | $144.89M | $137.40M | $146.76M | $139.32M | $134.42M | $184.84M | $136.70M | $136.62M | $136.48M | $168.04M | $95.72M | $135.34M | $134.13M | $179.72M | $76.63M | $75.29M | $73.27M | $79.92M | $70.75M | $68.20M | $66.28M | $77.18M | $70.83M | $69.75M |
| Low Forecast | $154.31M | $150.68M | $150.68M | $142.47M | $148.03M | $144.89M | $144.89M | $137.40M | $140.05M | $138.19M | $134.42M | $123.23M | $134.85M | $136.62M | $136.48M | $112.03M | $63.81M | $135.34M | $134.13M | $119.82M | $76.63M | $75.29M | $73.27M | $53.28M | $70.75M | $68.20M | $66.28M | $51.46M | $70.83M | $69.75M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.14% | - | 1.11% | 1.09% | 1.79% | 1.13% | 1.18% | 1.02% | 1.06% | 0.99% | 1.01% | 1.09% | 1.04% | 1.04% | 1.01% | 1.12% | 1.00% | 0.94% |
ICU Medical's average Quarter SG&A projection for Mar 24 is $154.04M, based on 1 Wall Street analysts, with a range of $123.23M to $184.84M. The forecast indicates a -0.37% fall compared to ICUI last annual SG&A of $154.62M (Dec 23).
ICU Medical EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 4 | 6 | 4 | 4 | 7 | 4 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | $-0.71 | - | $-0.41 | $-0.41 | $-0.65 | $-0.55 | $-0.31 | $-1.61 | $0.94 | $1.47 | $1.34 | $1.12 | $1.24 | $1.19 | $0.91 | $0.81 | $1.00 | $1.29 |
| Avg Forecast | $2.36 | $2.19 | $2.10 | $1.69 | $2.00 | $1.84 | $1.75 | $1.36 | $1.48 | $1.25 | $1.00 | $0.82 | $1.19 | $1.39 | $1.60 | $1.43 | $1.56 | $1.46 | $1.66 | $1.80 | $1.64 | $1.80 | $1.64 | $1.50 | $1.51 | $1.31 | $1.24 | $1.63 | $1.63 | $1.62 |
| High Forecast | $2.36 | $2.19 | $2.10 | $1.69 | $2.00 | $1.84 | $1.75 | $1.36 | $1.54 | $1.25 | $1.00 | $0.82 | $1.22 | $1.39 | $1.60 | $1.43 | $1.58 | $1.46 | $1.66 | $1.80 | $1.64 | $1.80 | $1.64 | $1.50 | $1.51 | $1.31 | $1.24 | $1.63 | $1.63 | $1.62 |
| Low Forecast | $2.36 | $2.19 | $2.10 | $1.69 | $2.00 | $1.84 | $1.75 | $1.36 | $1.42 | $1.25 | $1.00 | $0.82 | $1.14 | $1.38 | $1.60 | $1.43 | $1.54 | $1.46 | $1.66 | $1.80 | $1.64 | $1.80 | $1.64 | $1.50 | $1.51 | $1.31 | $1.24 | $1.63 | $1.63 | $1.62 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | -0.60% | - | -0.26% | -0.29% | -0.42% | -0.38% | -0.19% | -0.89% | 0.57% | 0.82% | 0.82% | 0.75% | 0.82% | 0.91% | 0.73% | 0.50% | 0.61% | 0.80% |
According to 1 Wall Street analysts, ICU Medical's projected average Quarter EPS for Mar 22 is $1.80, with a low estimate of $1.80 and a high estimate of $1.80. This represents a 91.49% increase compared to ICUI previous annual EPS of $0.94 (Dec 21).
ICU Medical Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| COO | Cooper Companies | $98.50 | $250.86 | 154.68% | Buy |
| HAE | Haemonetics | $68.89 | $107.00 | 55.32% | Buy |
| ATR | AptarGroup | $158.42 | $200.00 | 26.25% | Buy |
| HOLX | Hologic | $71.77 | $87.33 | 21.68% | Buy |
| AKYA | Akoya Biosciences | $2.96 | $3.50 | 18.24% | Buy |
| ICUI | ICU Medical | $169.87 | $190.50 | 12.14% | Buy |
| ANGO | AngioDynamics | $12.51 | $13.00 | 3.92% | Buy |
| XRAY | DENTSPLY SIRONA | $19.62 | $20.00 | 1.94% | Hold |
| MMSI | Merit Medical Systems | $109.03 | $105.60 | -3.15% | Buy |
| ATRC | AtriCure | $42.10 | $39.67 | -5.77% | Buy |
| NVST | Envista | $21.77 | $20.29 | -6.80% | Hold |